Brawn Biotech Ltd.
Snapshot View

19.20 0.00

07 December 2022, 03:40:00 PM
Volume: 2,676

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.brawnbiotech.com
Market Cap 5.75 Cr.
Enterprise Value(EV) 4.57 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -3.86 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 34.96 Trailing Twelve Months Ending 2022-09
Book Value / Share 23.25 Trailing Twelve Months Ending 2022-09
Price to Book Value 0.82 Calculated using Price: 19.15
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.30 Cr. 3,000,300 Shares
FaceValue 10
Company Profile
Brawn Pharmaceuticals was incorporated in the year 1985 it operates in health care sector in India and outside India. It has started its business by selling pharmaceutical formulations manufactured by other company's loan license basis. The company is located in New Delhi, India.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
+5.49%
1 Month
-1.79%
3 Month
-4.48%
6 Month
+6.37%
1 Year
+1.32%
2 Year
-12.33%
5 Year
-68.65%
10 Year
+82.34%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 3.14 5.91 18.15 22.39 17.62 16.37 6.60 -6.10 -20.53
Return on Capital Employed (%) 8.07 11.98 26.39 29.04 27.75 23.03 9.74 -3.57 -25.66
Return on Assets (%) 1.06 2.05 6.80 9.01 6.49 5.93 2.77 -3.24 -12.23

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 5 5 6 7 8 9 9 9 7 7
Non Curr. Liab. 0 0 0 0 0 0 0 0 0 -1
Curr. Liab. 9 9 8 10 15 14 11 5 6 7
Minority Int.
Equity & Liab. 14 14 14 17 22 22 20 14 13 13
Non Curr. Assets 3 3 3 0 1 1 1 1 1 0
Curr. Assets 11 11 11 17 22 22 19 13 12 13
Misc. Exp. not W/O
Total Assets 14 14 14 17 22 22 20 14 13 13

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 38 39 47 61 56 65 50 35 9 17
Other Income 1 0 0 1 0 1 0 0 0
Total Income 38 39 47 61 56 66 50 35 9 17
Total Expenditure -37 -38 -45 -59 -54 -64 -49 -36 -11 -18
PBIDT 1 1 1 2 2 2 1 0 -2 -2
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 -1 0 0 0 0 0
Exceptional Items -1
PAT 0 0 1 1 1 1 1 -1 -2 -1
Adjusted EPS 0 1 3 5 4 4 2 -2 -5 -4

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 1 -2 0 0 0 0
Cash Fr. Inv. 0 0 0 0 1 0 0
Cash Fr. Finan. 0 0 0 0 0 0 0 0 0
Net Change 0 0 0 0 2 -2 0 0 0
Cash & Cash Eqvt 0 0 0 0 2 0 1 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 53.71 53.71 53.71 53.71 53.71 53.71 53.71 53.73 53.73
Public 46.29 46.29 46.29 46.29 46.29 46.29 46.29 46.27 46.27
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 12 Nov 2022
Board Meeting Outcome for Outcome Of Board Meeting And Submission Of Unaudited Financial Results For The Quarter 30.09.2022.
Board of Directors of the Company at its meeting held on today i.e. 12th November 2022 inter-alia considered and approved/noted Standalone Un-audited Financial Results along with Limited Review Report by the Companys Statutory Auditor for the quarter and half year ended 30th September 2022
Fri, 04 Nov 2022
Board Meeting Intimation for Approval Of Financial Results For The Quarter Ended On 30.09.2022
BRAWN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 inter alia to consider and approve Pursuant to Regulation 29 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 notice is hereby given that the meeting of the Board of Directors of Brawn Biotech Limited is scheduled to be held on Saturday 12th November 2022 to consider approve and take on record the Un-Audited Financial Results of the company for the quarter and half-year ended on 30th September 2022.
Sat, 08 Oct 2022
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 we are enclosing herewith a copy of Certificate received from RCMC Share Registry Private Limited the Registrar and Share transfer Agent of the Company for the quarter ended September 30 2022.

Technical Scans View Details >>

Wed, 07 Dec 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
5 SMA Crossing 20 SMA From Below 5 SMA Crossing 20 SMA From Below

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 244,600.20 1,017.75 -1.5%
Cipla Ltd. 89,185.65 1,105.30 -0.4%
Divi's Laboratories Ltd. 88,620.05 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. 72,619.02 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. 67,995.76 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. 55,031.23 1,629.00 +0.9%
Abbott India Ltd. 42,993.71 20,208.95 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 59.59 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-09 34.76 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 29.63 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.32 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 80.98 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.05 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-09 48.76 20,208.95 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.60 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-09 4.08 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 7.31 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.49 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.36 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.03 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-09 15.84 20,208.95 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 0.00 20,208.95 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 29.95 20,208.95 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 29.95 20,208.95 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,208.95 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 798.70 20,208.95 +0.1%

FAQ's On Brawn Biotech Ltd.

What is Brawn Biotech share price?

Can I buy Brawn Biotech shares now?

What is the Market Cap of Brawn Biotech?

What are the key metrics to analyse Brawn Biotech?

What is the 52 Week High and Low of Brawn Biotech?

What is the trend of Brawn Biotech share price?